Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Personalized Medicine Needs Personalized Advocacy To Advance, PhRMA Says

This article was originally published in The Pink Sheet Daily

Executive Summary

CEO Castellani says message has to be specifically tailored to payers, patient advocates and regulators.

You may also be interested in...



CER Dissemination: PCORI Could Help Raise The Bar For Clinical Guidelines

Roundtable panelists, including the chair of the Patient Centered Outcomes Research Institute's communications committee, discuss the future of disseminating results of comparative effectiveness research.

PDUFA V Agreement Appears Set Between FDA And Industry

Final package expected to be published in late summer following clearance by the administration.

Regulatory Workaround, Not Statutory Changes, Better For Personalized Medicine Development, FDA Commissioner Hamburg Says

FDA Commissioner Margaret Hamburg said that working within the current regulatory framework rather than seeking new statutory authority to address the development of drugs and accompanying diagnostic tests would be preferable to address personalized medicine questions at the agency

Topics

UsernamePublicRestriction

Register

OM013658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel